LAB Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own LAB shares is 187, representing 72.12% of the company's common stock.

NUMERIC INVESTORS LLC, in the last quarter, reduced its stake in LAB by -96.01% restricting it's holding to 11.7 thousand shares of worth nearly $46.00. DRILL CRAIG A also lessened -100% of the LAB shares from its portfolio, reducing its holding to 0 shares of worth N/A. SIGNIA CAPITAL MANAGEMENT LLC also shunned LAB shares holding by -100% last quarter which brought its holding to 0 shares worth N/A.

As per its latest 13F filing, BOSTON PROVIDENT, L.P. increased its stake in LAB by 3.42% in the last quarter. The institutional holder raised its holding to 1.15 million shares having worth more than $4.52K. GREEN ARROW CAPITAL MANAGEMENT LLC also added 100% more shares of LAB to its portfolio, raising its holding to 681.5 thousand shares of worth $2.68K. GARDNER LEWIS ASSET MANAGEMENT L P also increased its LAB shares holding by 100% which brought its holding to 236.79 thousand shares worth $931.00.

The insider with the most stakes in LAB is Casdin Partners Master Fund, L.P. , at the company. Additionally, LAB stock is highly held by 10 percent owner Caligan Partners LP and JOHNSON DAVID EDWARD among others.

Company executives, directors, and other insiders own 1.95% percent of Standard BioTools Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which LAB insiders have sold stock, totaling 0 shares. Insiders that have sold shares include LINTHWAITE STEPHEN CHRISTOPHER, LEVIN EASTERLY PARTNERS LLC, and BARTHELEMY NICOLAS.

There have been 22 transaction(s) during the past 6-months in which Standard BioTools Inc. insiders have bought stock, totalling 9347042 shares

Around 1.09B Standard BioTools Inc. shares are held by insiders, which represents about 1.95% of LAB stock.

LAB , Casdin Partners Master Fund, L.P. holds the largest portfolio of the company's shares. LAB shares owned by Casdin total nearly 54.03 million.

COWEN INVESTMENT MANAGEMENT LLC is the largest institutional owner in LAB which holds 2 million shares worth $7.86K or 18.6% of the total LAB shares outstanding followed by BOSTON PROVIDENT, L.P. with ownership of 1.15 million shares representing 10.69% of the LAB ownership. GREEN ARROW CAPITAL MANAGEMENT LLC is the third largest stakeholder with 681.5 thousand shares or 6.34% of the ownership worth more than $2.68K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the LAB is concerned, it is a stock which is optionable.

Number of LAB shares short is 22.25M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 371.15M shares of LAB are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, LAB has 48.76M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for LAB is 10.19.